Serdaen
FDA Label NDC 56149-001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Browne Hansen Llc for the product Serdaen (NDC 56149-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, indications & usage, otc - keep out of reach of children, warnings, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active Ingredient

Chlorhexidine Diacetate 1%

Inactive Ingredient

Inactive Ingredients

Water, Cola Det SDC, Sodium Xylem Sulfate, Tocopheryl Acetate, Fragrance

Otc - Purpose

Purpose

Antimicrobial

Indications & Usage

Uses

Prevent overgrowth of bacteria prior to surgical procedure

Prevent recurrent bacterial infections

Prevent infections around superficial wounds

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help

or contact a poison control center right away.

Warnings

Warnings

For external use only.

Do not use:

If allergic to Chlorhexidine or other ingredients in formulation

In contact with the genital area

On wounds that exceed the superficial layer of skin.

Otc - When Using

When using this product

Avoid eye contact. Should contact occur,

rinse thoroughly with water.

Otc - Stop Use

Discontinue use and consult a health care practitioner

if irritation or allergic reaction develops.

Dosage & Administration

Directions

Apply liberally to moistened area, wash and rinse thoroughly.

All product should be rinsed and dried immediately

Package Label.Principal Display Panel

Copy Of Label (Serdaen One)

Copy Of Label (Serdaen One)

* Please review the disclaimer below.